Cardiac rehabilitation devices are used by patients suffering from heart diseases. These rehabilitation devices aid the patients in reducing the danger of heart attacks and heart diseases. Counseling sessions, psychosocial interventions, physical activity counseling, nutritional counseling, hypertension, diabetes & weight management, and exercise are some of the activities that aid in monitoring a patient’s disease.
Strategic insights for the North America Cardiac Rehabilitation provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2020 | US$ 763.51 Million |
Market Size by 2028 | US$ 1,258.21 Million |
Global CAGR (2021 - 2028) | 6.5% |
Historical Data | 2018-2019 |
Forecast period | 2021-2028 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The geographic scope of the North America Cardiac Rehabilitation refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The North America cardiac rehabilitation market is expected to reach US$ 1,258.21 million by 2028 from US$ 763.51 million in 2020; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The growth of the market is attributed to some key driving factors such as rising incidences of cardiovascular diseases, and growing adoption of tele-cardiac rehabilitation. However, the high cost of the cardiac rehabilitation equipment is expected to obstruct the growth of the market to a certain extent during the forecast years.
In the last few decades, a few risk factors for cardiovascular diseases (CVDs) have improved, while others have worsened. At the same time, Americans’ average body mass index and prevalence of diabetes have augmented as the population continues to have made the CVD more prevalent. The prevalence of lifestyle diseases such as hypertension, obesity, dyslipidemia, and diabetes, which are major risk factors for CVD, is also rising. Heart disease has endured an important cause of death at the global level for the past 20 years. The global patterns of total CVD have significant consequences for clinical practice and public health policy development. Therefore, a substantial increase in cardiovascular diseases is anticipated to positively influence the market growth during the forecast period. The breakthrough technologies such as e-cardiology and e-health have evolved considerably over the past years and are anticipated to impact CVD management and prevention. Also, tele-cardiac rehabilitation probably decreases barriers of distance, time, and cost. The family members of cardiac patients found telerehabilitation technologies a valuable digital toolbox in the rehabilitation process. Therefore, the significant growing adoption of tele-cardiac rehabilitation in the healthcare sector is anticipated to positively influence market growth during the forecast period.
North American region is highly affected due to the outbreak of the COVID-19 pandemic. As various hospitals and healthcare organizations are struggling with the spread of disease, various medical device companies have diverted their focus in producing personal protection equipment, diagnostic kits, and monitoring systems. In addition, the COVID-19 pandemic is perplexing healthcare institutions in the region with unprecedented operational and clinical challenges. Moreover, shift of priorities from cardiovascular treatment to corona virus diagnosis and treatment devices are leading to decline in cardiac rehabilitation, leading to decline in market growth up to certain extent. Therefore, it expected that the market for the cardiac rehabilitation would witness slow growth in the coming one or two years.
Based on product, the North America cardiac rehabilitation market is segmented into heart rate monitor, stabilization balls, treadmill, rower, elliptical trainer, blood pressure monitor, stationary bicycle, and others. The treadmill segment held the largest share of the market in 2020, whereas the blood pressure monitor segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on application, the North America cardiac rehabilitation market is segmented into angioplasty, coronary artery disease, cardiomyopathy, cholesterol management, diabetes, and lung transplant. The angioplasty segment held the largest share of the market in 2020, and the coronary artery disease segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on end user, the North America cardiac rehabilitation market has been segmented into hospitals & clinics, specialty hospitals, home healthcare, cardiac rehabilitation centers, and others. The cardiac rehabilitation centers segment held the largest share of the market in 2020, and home healthcare segment is estimated to register the highest CAGR in the market during the forecast period.
A few of the primary and secondary sources associated with this report on the North America cardiac rehabilitation market are the Centers for Disease Control and Prevention (CDC), American College of Cardiology (ACC), Mexican Institute of Social Security (IMSS) and Canadian Association of Cardiovascular Prevention and Rehabilitation (CACPR).
The North America Cardiac Rehabilitation Market is valued at US$ 763.51 Million in 2020, it is projected to reach US$ 1,258.21 Million by 2028.
As per our report North America Cardiac Rehabilitation Market, the market size is valued at US$ 763.51 Million in 2020, projecting it to reach US$ 1,258.21 Million by 2028. This translates to a CAGR of approximately 6.5% during the forecast period.
The North America Cardiac Rehabilitation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Cardiac Rehabilitation Market report:
The North America Cardiac Rehabilitation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Cardiac Rehabilitation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Cardiac Rehabilitation Market value chain can benefit from the information contained in a comprehensive market report.